Ascendis Pharma aims to raise USD 112 million

Danish biotech company Ascendis Pharma has announced a public offering of ADSs in a bid to raise up to USD 112 million.

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles